1. Home
  2. ITRI vs ALKS Comparison

ITRI vs ALKS Comparison

Compare ITRI & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Itron Inc.

ITRI

Itron Inc.

HOLD

Current Price

$97.77

Market Cap

4.4B

Sector

Industrials

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$33.44

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITRI
ALKS
Founded
1977
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.7B
IPO Year
1993
1991

Fundamental Metrics

Financial Performance
Metric
ITRI
ALKS
Price
$97.77
$33.44
Analyst Decision
Buy
Strong Buy
Analyst Count
10
13
Target Price
$135.78
$42.85
AVG Volume (30 Days)
476.3K
2.0M
Earning Date
02-17-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
14.43
2.44
EPS
5.57
2.02
Revenue
$2,408,401,000.00
$1,521,338,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.70
$22.50
P/E Ratio
$17.53
$16.70
Revenue Growth
0.14
1.08
52 Week Low
$90.11
$25.17
52 Week High
$142.00
$36.45

Technical Indicators

Market Signals
Indicator
ITRI
ALKS
Relative Strength Index (RSI) 49.61 74.95
Support Level $96.31 $31.09
Resistance Level $101.21 $34.67
Average True Range (ATR) 2.58 1.13
MACD 0.34 0.54
Stochastic Oscillator 48.91 84.24

Price Performance

Historical Comparison
ITRI
ALKS

About ITRI Itron Inc.

Itron Inc provides solutions that measure, manage, and analyze energy and water use. It operates under the Itron brand and manages and reports under three operating segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment includes hardware products used for measurement, control, or sense that do not have communications capability embedded for use with broader Itron systems. The Networked Solutions segment includes a combination of communicating devices, network infrastructure, and associated application software designed and sold as a complete solution. The Outcome segment includes their value-added, enhanced software and services which manage, organize, analyze, and interpret data to improve decision-making and maximize operational profitability.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: